Third, the prospective study design allows for timely interrogation of IL-17A and its association with both inpatient and post-discharge outcomes, with emphasis in mortality and MAKE which are important epidemiological outcomes in AKI and critical care. The gene discussed is IL17A; the disease is acute kidney injury.